CIRCULOGENE
Dr. James Cantrell has practiced Oncology-Hematology over 30 years and was a co-founder and President of Alabama Oncology, LLC and Medical Director of the Bruno Cancer Center. He has published over 20 peer reviewed articles and abstracts, and has been a member of numerous professional organizations, including the US Oncology Research Program. He earned his MD and completed an Internal Medicine Residency at Emory University School of Medicine, and Fellowships in Medical Oncology and Hematology at Georgetown University Hospital.
This person is not in the org chart
This person is not in any offices
CIRCULOGENE
Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence.